Trial Information

Summary: A study to compare the effectiveness and safety of investigational drug(s) regimens to effectively prevent a second stroke.

Inclusion:

• Male or female patient of at least 55 years of age.
• Stroke occurred due to impaired blood flow to the brain.
• Stroke must have occurred within 90 days of entry into the study.
• Patient is neurologically and clinically stable.

Exclusion Criteria:

• Patient is unable to take medications by mouth.
• Patient is unable to give informed consent.
• Patient has a previous diagnosis of (congestive) heart failure or currently symptomatic.
• The stroke was caused by interventional procedure.
• Patient has abnormal blood pressure.
• Patient has pre-stroke history of dementia requiring institutional care.
• Patient has severely impaired kidney and/or liver functions.
• Patient has active stomach ulcer.
• Patient has had severe coronary artery disease within previous 3 months.
• Patient has history of abnormal bleeding.
• Women who are breast feeding, pregnant or are of childbearing potential who do not use a medically acceptable form of contraception.
• Patient is being treated with certain medications.
• Patient who has asthma, nasal allergy and nasal polyp – all of them present at the same time.
• Patient who participated in another study within the last 30 days.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.